Analysis· The Conversation
RFK Jr. loosens access to unapproved peptides: A health law scholar explains what consumers need to know
By Ana Santos Rutschman, Professor of Law, Villanova University, The Conversation · November 10, 2026
Compounding pharmacies will now be able to sell 6 popular peptides, despite the fact they have not been proved safe and effective.
Continue readingRead the full story at The ConversationMore in Analysis
Analysis· The Conversation
US national debt keeps rising after years of tax cuts – and this will make policymaking all the more difficult
By Hinckley Jones-Sanpei, Public Policy Researcher, University of Denver · 2h ago
Analysis· The Conversation
When a Walmart closes, what happens to nearby stores?
By Vivek Astvansh, Associate Professor of Quantitative Marketing and Computational Data Science, Binghamton University, State University of New York, Preetinder Kaur, Assistant Professor of Marketing, University of Guelph, Pushpinder Gill, Assistant Professor of Marketing, Toronto Metropolitan University · 2h ago
Analysis· The Conversation
COP31: Governments are failing to rein in emissions from their own power plants
By Don Grant, Professor of Sociology, University of Colorado Boulder · 2h ago